We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $767M
1-Year Est. Return 119.71%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+119.71%
3 Year Est. Return
+244.81%
5 Year Est. Return
+382.5%
10 Year Est. Return
+2,655.81%
AUM
$871M
AUM Growth
+$146M
Cap. Flow
+$107M
Cap. Flow %
12.24%
Top 10 Hldgs %
47.29%
Holding
141
New
32
Increased
44
Reduced
18
Closed
28

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$43.2M
2
BMY icon
Bristol-Myers Squibb
BMY
+$32M
3
VTRS icon
Viatris
VTRS
+$17.7M
4
ARGX icon
argenx
ARGX
+$12.1M
5
ACGN
Aceragen Inc
ACGN
+$11.5M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$21.4M
2
AMGN icon
Amgen
AMGN
+$18.5M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$15.6M
4
BIIB icon
Biogen
BIIB
+$14.5M
5
PFE icon
Pfizer
PFE
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 77.29%
2 Miscellaneous 12.29%
3 Technology 4.8%
4 Industrials 2.36%
5 Financials 1.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMX
101
DELISTED
Terminix Global Holdings, Inc.
TMX
$395K 0.05%
14,184
– –
ABUS icon
102
Arbutus Biopharma
ABUS
$1B
$378K 0.04%
+40,000
New +$397K
EIDX
103
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$315K 0.04%
31,522
+20,694
+191% +$340K
BNTC icon
104
Benitec Biopharma
BNTC
$396M
$294K 0.03%
+471
New +$322K
LOW icon
105
Lowe's Companies
LOW
$109B
$287K 0.03%
+2,500
New +$260K
CLRB icon
106
Cellectar Biosciences
CLRB
$22.7M
$263K 0.03%
+292
New +$344K
ULTI
107
DELISTED
Ultimate Software Group Inc
ULTI
$258K 0.03%
800
– –
CISN
108
DELISTED
Cision Ltd. Ordinary Share
CISN
$252K 0.03%
15,000
– –
SITE icon
109
SiteOne Landscape Supply
SITE
$3.89B
$226K 0.03%
3,000
– –
CMCSA icon
110
Comcast
CMCSA
$81.3B
$212K 0.02%
+5,993
New +$212K
CUE icon
111
Cue Biopharma
CUE
$275M
$181K 0.02%
+667
New +$193K
AMGN icon
112
Amgen
AMGN
$205B
– –
-100,000
Closed -$18.5M
BIIB icon
113
Biogen
BIIB
$32.4B
– –
-50,000
Closed -$14.5M
DK icon
114
Delek US
DK
$4.99B
– –
-24,533
Closed -$1.23M
KRNT icon
115
Kornit Digital
KRNT
$661M
– –
-130,831
Closed -$2.33M
KURA icon
116
Kura Oncology
KURA
$1.04B
– –
-351,953
Closed -$6.41M
LRCX icon
117
Lam Research
LRCX
$337B
– –
-145,970
Closed -$2.52M
META icon
118
Meta Platforms (Facebook)
META
$1.74T
– –
-19,100
Closed -$3.71M
MHK icon
119
Mohawk Industries
MHK
$8.7B
– –
-1,100
Closed -$236K
MRVL icon
120
Marvell Technology
MRVL
$216B
– –
-109,842
Closed -$2.35M
NGNE icon
121
Neurogene
NGNE
$649M
– –
-12,881
Closed -$683K
NICE icon
122
Nice
NICE
$6.17B
– –
-60,043
Closed -$6.23M
OEF icon
123
PUT
iShares S&P 100 ETF
OEF
$20.3B
– –
-150,000
Closed -$24.6M
PFE icon
124
Pfizer
PFE
$158B
– –
-411,060
Closed -$14.1M
RCKT icon
125
Rocket Pharmaceuticals
RCKT
$384M
– –
-34,475
Closed -$677K
2 3 4
5
6

Similar funds

ISWM
Independent Solutions Wealth Management Williamsville, New York $766M AUM 31.53% 1-Year Est. Return
ACP
Albar Capital Partners London, United Kingdom $767M AUM 61.96% 1-Year Est. Return
NIM
Nexus Investment Management Toronto, Ontario, Canada $767M AUM 30.97% 1-Year Est. Return
ACM
Arvin Capital Management Austin, Texas $766M AUM 36.51% 1-Year Est. Return
CBT
Crews Bank & Trust Wauchula, Florida $766M AUM 19.5% 1-Year Est. Return
SPIA
Strategic Point Investment Advisors Providence, Rhode Island $767M AUM 17.58% 1-Year Est. Return
CNB
Camden National Bank Camden, Maine $767M AUM 14.32% 1-Year Est. Return
HI
Hendershot Investments Centreville, Virginia $766M AUM 10.81% 1-Year Est. Return

Sphera Funds Management's Q3 2018 Portfolio in Review

As of Q3 2018, Sphera Funds Management held 141 positions worth $871M, up 20% from $725M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sphera Funds Management deployed $107M of net new capital in Q3 2018, opening 32 new positions and adding to 44 existing holdings. Its largest new stake was Johnson & Johnson: 325,000 shares worth $44.9M.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 74% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $15.6M trimmed.

  • Sphera Funds Management's largest Q3 2018 buy was Johnson & Johnson: 325,000 shares worth $44.9M.
  • Sphera Funds Management added most to Viatris in Q3 2018, an estimated $17.7M increase.
  • Sphera Funds Management's biggest Q3 2018 reduction was Alnylam Pharmaceuticals, cutting an estimated $15.6M.
  • Sphera Funds Management fully exited Shire pic in Q3 2018, selling an estimated $21.4M.
  • Sphera Funds Management's ten largest holdings make up 47% of its $871M portfolio in Q3 2018.
  • Sphera Funds Management opened 32 new positions and closed 28 in Q3 2018.
  • Sphera Funds Management's portfolio value rose 20% quarter-over-quarter to $871M.

Based on Sphera Funds Management's 13F filing for Q3 2018, filed 14 Nov 2018.